Conagra Brands is navigating significant financial hurdles with a projected 0.5% annual revenue decline, despite aspirations to reach $11.4 billion in revenue by 2028. Recently, the company reported a staggering earnings decrease of approximately $294 million, reflecting a steep 39.7% decline in stock value over the past year. Analysts, including those from Morgan Stanley, maintain a cautious outlook with an 'Equal Weight' rating, expressing concerns about potential impacts from cuts to the Supplemental Nutrition Assistance Program (SNAP) on sales. This follows a consistent pattern of declining earnings, a recent downgrade from BNP Paribas, and adjustments to fiscal expectations amid a challenging market environment fueled by shifting consumer preferences and rising operational costs.
Click a month on the chart to update the report below.
